Furthermore, the genetically engineered mouse model of cirrhosis-associated HCC with hepatocyte-specific Smyd5 KO indicated that the SMYD5-RPL40 K22me3 pathway is critical in tumor initiation and progression (Fig. 6e–g). The gene discussed is SMYD5; the disease is hepatocellular carcinoma.